期刊文献+

小儿恶性淋巴瘤的细胞遗传学研究 被引量:1

Acytogeneticalstudyonchildhoodmalignantlymphoma
原文传递
导出
摘要 为寻找小儿恶性淋巴瘤(ML)染色体改变的规律及与其病理组织学的相关性,并探讨染色体重排与ML的关系,应用淋巴结改良直接法、短期培养法及骨髓短期培养法对24例小儿ML进行细胞遗传学研究,23例获得满意分裂相。结果表明:全部淋巴结染色体及4例骨髓染色体显示克隆性异常。非霍奇金淋巴瘤(NHL)染色体众数多为二倍体及亚二倍体,分布似与组织学分型有关;霍奇金淋巴瘤(HD)染色体众数从亚二倍体到四倍体。染色体结构异常以6q-较多见。本组出现的染色体相互易位大都涉及到14q32及其附近,表明14q32的断裂重排与ML的发生有关。 Inordertodiscovertheregularityofchromosomeabnormalitiesinmalignantlym-phoma(ML)anditsrelevancetohistopatholoigy,andtostudytherelationshipbetweentheoccur-renceofMLandchromosomeabnormalities,weearriedoutacytogeneticalstudyof24childrenwithML.Outofthe24cases,mitoticcelsthatcouldbeusedforanalysiswereobtainedin23.Theresultshowedthattheclonalabnormalitieswerefoundinlymphnodechromosomesofalthecasesandinthebonemarrowchromosomesof4cases.Incasesofnon-Hodgkin′slymphoma(NHL),themodalnumberofchromosomeswasmostlydiploidorhyperdiploidandthedistributionappearedtobecorre-latedwiththetypeofML.Ontheotherhand,inHodgkin′sdiseasesthemodalnumberofchromo-somesvariedfrombiploidtofourploid.Thecommonabnormalchromosomestructurewas6q-andthereciprocaltranslocationsofchromosomeweremostlyinvolvedinthe14q32ornearit.Theresultsuggeststhattheaberrationandrearrangementof14q32beassociatedwiththedevelopmentofML.
出处 《中华儿科杂志》 CAS CSCD 北大核心 1996年第3期161-163,共3页 Chinese Journal of Pediatrics
关键词 淋巴瘤 恶性淋巴瘤 细胞遗传学 儿童 LymphomaChromosomes
  • 相关文献

参考文献3

  • 1王俊华,临床血液学杂志,1993年,6卷,66页
  • 2周焕庚,人类染色体,1987年
  • 3团体著者,肿瘤,1985年,5卷,277页

同被引文献27

  • 1邹俊,张明智,廖世秀,杨艳丽,张晓梅,王应太.恶性淋巴瘤患者的染色体畸变[J].肿瘤基础与临床,2006,19(2):103-105. 被引量:1
  • 2GangSong,GaoliangOuyang,ShidengBao.The activation of Akt/PKB signaling pathway and cell survival[J]. Journal of Cellular and Molecular Medicine . 2007 (1)
  • 3M. Osaki,M. Oshimura,H. Ito.PI3K-Akt pathway: Its functions and alterations in human cancer[J]. APOPTOSIS . 2004 (6)
  • 4Sen R,Baltimore D.Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell . 1986
  • 5Marina Y. Konopleva,Craig T. Jord.Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting. Japanese Journal of Clinical Oncology . 2011
  • 6Tokunaga Eriko,Oki Eiji,Egashira Akinori,Sadanaga Noriaki,Morita Masaru,Kakeji Yoshihiro,Maehara Yoshihiko.Deregulation of the Akt pathway in human cancer. Current Cancer Drug Targets . 2008
  • 7Coffer P J,Jin J,Woodgett J R.Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochemical Journal . 1998
  • 8LQiu,LZhang,LZhu,DYang,ZLi,KQin,XMi.??PI3K/Akt mediates expression of TNF‐α mRNA and activation of NF‐κB in calyculin A‐treated primary osteoblasts(J)Oral Diseases . 2008 (8)
  • 9Mehra Sukvarsha,Messner Hans,Minden Mark,Chaganti R S K.Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chromosomes and Cancer . 2002
  • 10Mattias Berglund,Gunilla Enblad,Ulf Thunberg,Rose-Marie Amini,Christer Sundstr?m,G?ran Roos,Martin Erlanson,Richard Rosenquist,Catharina Larsson,Svetlana Lagercrantz.Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma. Modern Pathology . 2006

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部